Effects of High-Dose Atorvastatin in Patients ≥65 Years of Age With Acute Coronary Syndrome (from the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering [MIRACL] Study) - Concepedia

Concepedia

Publication | Closed Access

Effects of High-Dose Atorvastatin in Patients ≥65 Years of Age With Acute Coronary Syndrome (from the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering [MIRACL] Study)

63

Citations

3

References

2007

Year

Anders Olsson, Gregory G. Schwartz, Michael Szarek, Don Luo, M. J. Jamieson

The American Journal of Cardiology

Cardiovascular DiseaseHigh-dose AtorvastatinAcute Coronary SyndromeHyperlipidemiaPatients ≥65 YearsDyslipidemiaPublic HealthMedicineCardiologyEpidemiologyCoronary Artery DiseaseAcute Myocardial Infarction

References

	Year	Citations

Page 1